Novavax’s Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Received Authorization in the EU
On Oct. 9, 2024, Novavax announced that the European Commission had granted Marketing Authorization for Novavax’s updated 2024-2025…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
COVID-19 hospitalization remained higher among older adults
On Oct. 4, 2024, the Centers for Disease Control and Prevention (CDC) published data that showed older adults…
COVID-19 Symptoms Reduced Among U.S. Healthcare Personnel Receiving Additional Vaccine Doses
On Sept. 25, 2024, U.S. healthcare workers receiving additional vaccine doses during the Omicron period (December 2021 to…
Biotechnology | COVID-19 | Diagnostics | Life Science News | NIH | Oncology | Therapeutics | Women's Health
New cancer diagnoses did not rebound as expected following pandemic
On Sept. 24, 2024, researchers at the National Institutes of Health (NIH) reported results of a study that…
Agriculture | Biotechnology | Chemical | Diagnostics | Environmental | EPA | Life Science News | Therapeutics
Air pollution, high temperatures, and metabolic risk factors driving global increases in stroke, with latest figures estimating 12 million cases and over 7 million deaths from stroke each year
On Sept. 18, 2024, a study published in The Lancel reported that here has been a rapid rise…
Study Revealed How COVID-19 Infection Can Cause or Worsen Diabetes
On Sept. 13, 2024, researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the…
Novavax 2024-2025 COVID-19 Vaccine Available at Major U.S. Pharmacies
On Sep. 13. 2024, Novavax announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to…
Japan’s MHLW Approved CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
On Sept. 13, 2024, CSL Seqirus and sa-mRNA pioneer Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor…
Biotechnology | COVID-19 | Life Science News | Medical Device | Medicine | Pharmaceutical | Therapeutics | Vaccine
Covid-19 pandemic changed scientific publishing
On Sep. 9, 2024, Santo Fortunato, a professor at Luddy School of Informatics, reported that an international research…
Novavax Formula COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Aug. 30, 2024, Novavax announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) had received Emergency Use…
scientist-run Pathoplexus virus database vows to be transparently run and simple to use
On Aug. 29, 2024, a small team of scientists has launched an open-source database for some of the…
Vaccine Misinformation caused U.S. Covid-19 Vaccination rate to Drop
On Aug. 28, 2024, survey data from the Annenberg Public Policy Center (APPC) found that the number of…
Pfizer and BioNTech Received U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
On Aug. 22, 2024, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had approved…
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
CDC reported COVID-19 at highest level in two years
On Aug. 16, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that COVID-19 infections are…
WHO/Europe study confirmed lifesaving impact of vaccines against COVID-19 Summer Wave
On Aug. 8, the World Health Organization (WHO) announced results of a study that showed the introduction of…
BioNTech sued by UPenn over COVID-19 vaccine patent royalties
On Aug. 6, 2024, the University of Pennsylvania announced it had sued German biotechnology firm BioNTech n Pennsylvania…
Biotechnology | COVID-19 | Influenza | Life Science News | Plague | Vaccine | WHO
CEPI and WHO urge broader research strategy for countries to prepare for the next pandemic
On Aug. 1, 2024, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO) called…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics
Paxlovid led to better outcomes in hospitalized COVID cohort than Veklury or both drugs
On Jul. 24, 2024, the University of Hong Kong released a study that showed hospitalized COVID-19 patients treated…
Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | Vaccine | Veterinary
Cornell Study confirmed mammal-to-mammal avian flu spread
On Jul. 24, 2024, a team led by researchers at Cornell University announced a study that provides evidence…
Biotechnology | CDC | COVID-19 | Influenza | Life Science News | Vaccine
CDC Recommended Updated 2024-2025 COVID-19 and Flu Vaccines for Fall/Winter Virus Season
On Jun. 27, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) recommended the updated 2024-2025 COVID-19…
National Academies announced New Broad Definition of Long COVID
On Jun. 11, 2024, the National Academies of Sciences, Engineering, and Medicine released a new report that stated the…
BioNTech and CEPI Expanded Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
On May 29, 2024, BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) announced they were expanding their…
COVID-19 eliminated a decade of progress in global level of life expectancy
On May 24, 2024, the World Health Organization (WHO) revealed that the COVID-19 pandemic reversed the trend of…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science History | Life Science News | Vaccine
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
On May 17, 2024, researchers at Washington University School of Medicine in St. Louis announced a study had…
National Academies reported COVID-19 vaccines don’t cause many potential harms
On May 10, 2024, the National Academies of Sciences, Engineering, and Medicine reported that the COVID-19 vaccines made…
Novavax and Sanofi announced licensing agreement to co-commercialize COVID-19 vaccine and novel COVID-19-influenza combination vaccines
On May 10, 2024, Novavax announced that it had entered into a co-exclusive licensing agreement with Sanofi. The…
Moderna announced contract with Brazil to supply 12.5 million COVID-19 vaccines as part of national vaccination campaign
On Apr. 22, 2024, Moderna announced a contract with the Ministry of Health in Brazil (Ministerio da Saude)…
FDA issued EUA for Pemgarda (pemivibart) for pre-exposure prophylaxis of COVID-19 in certain adults and adolescents
On Mar. 22, 2024, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for Pemgarda…
Severe lung infection during COVID-19 caused damage to the heart
On Mar. 20, 2024, a National Institutes of Health-supported study reported that SARS-CoV-2, the virus that causes COVID-19,…
COVID reduced global life expectancy by 1.6 years
On Mar. 14, 2024, the Institute for Health Metrics and Evaluation (IHME) released all-cause mortality, life expectancy, and…